Cargando…
Inhibiting the Deubiquitinase UCHL1 Reduces SARS-CoV-2 Viral Uptake by ACE2
Coronavirus disease (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), remains a significant public health burden with limited treatment options. Many β-coronaviruses, including SARS-CoV-2, gain entry to host cells through the interaction of SARS-CoV-2 spike protein...
Autores principales: | Bednash, Joseph S., Johns, Finny, Farkas, Daniela, Elhance, Ajit, Adair, Jessica, Cress, Kirstin, Yount, Jacob S., Kenney, Adam D., Londino, James D., Mallampalli, Rama K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Thoracic Society
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10174169/ https://www.ncbi.nlm.nih.gov/pubmed/36730646 http://dx.doi.org/10.1165/rcmb.2022-0331OC |
Ejemplares similares
-
MicroID2: A Novel Biotin Ligase Enables Rapid Proximity-Dependent Proteomics
por: Johnson, Benjamin S., et al.
Publicado: (2022) -
The E3 ligase subunit FBXO45 binds the interferon-λ receptor and promotes its degradation during influenza virus infection
por: Tsai, MuChun, et al.
Publicado: (2022) -
Interferon Lambda Signaling in Macrophages Is Necessary for the Antiviral Response to Influenza
por: Mallampalli, Rama K., et al.
Publicado: (2021) -
Syrian hamsters as a model of lung injury with SARS-CoV-2 infection: Pathologic, physiologic, and detailed molecular profiling
por: BEDNASH, JOSEPH S., et al.
Publicado: (2022) -
Targeting the deubiquitinase STAMBP inhibits NALP7 inflammasome activity
por: Bednash, Joseph S., et al.
Publicado: (2017)